Improving the Appropriate Prescribing of Olanzapine for Chemotherapy-Induced Nausea and Vomiting: A Quality Improvement Initiative for the Outpatient Oncology Practice
Audit data obtained following the implementation of the QI project revealed a statistically significant improvement, which supported the hypothesis that providing education based on the PDSA model is an effective method to improve the compliance rate of appropriate olanzapine prescribing for CINV in patients receiving HEC. The result reflects the growing body of evidence confirming the validity of the PDSA model.
Authors
- Jatin Rana
- M Krupp
- Megan Bowers (ORCID: https://orcid.org/0000-0002-5930-7635)
- Ryan L Gennette
- Katherine Dontje
- Suzanne Fadley
- Eman Issawi
Institutions
- Michigan State University (US)
Publication Details
- Journal
- Journal of the Advanced Practitioner in Oncology
- Published
- 2025-11-10
- DOI
- https://doi.org/10.6004/jadpro.2025.16.7.29
- Primary Topic
- Nausea and vomiting management
- Type
- article
- Field-Weighted Citation Impact
- 0.00